Merck And Moderna Diverge On Cancer Vaccine Results. Do They Still Have A Viable Drug?

Moderna and Merck stock diverged Friday as investors digested the early release of their cancer vaccine data. The post Merck And Moderna Diverge On Cancer Vaccine Results. Do They Still Have A Viable Drug? appeared first on Investor's Business Daily.